pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Anti-Obesity Drugs Market Report 2017


Published On : Aug 2017

Category : Pharmaceutical

No. of Pages : 118 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Anti-Obesity Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Anti-Obesity Drugs for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anti-Obesity Drugs market competition by top manufacturers/players, with Anti-Obesity Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Prescription Drugs
OTC Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Anti-Obesity Drugs for each application, including
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

In the recent times, the global market for Emea europe middle east and africa anti obesity drugs market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa anti obesity drugs market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa anti obesity drugs market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa anti obesity drugs market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa anti obesity drugs market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa anti obesity drugs market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa anti obesity drugs market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa anti obesity drugs market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa anti obesity drugs market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa anti obesity drugs market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa anti obesity drugs market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa anti obesity drugs market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa anti obesity drugs market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Anti-Obesity Drugs
Figure EMEA Anti-Obesity Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Anti-Obesity Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Prescription Drugs Product Picture
Figure OTC Drugs Product Picture
Figure EMEA Anti-Obesity Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Anti-Obesity Drugs by Application in 2016
Figure 6-18 Callant Examples
Figure 18-30 Adult Examples
Figure 30-60Middle-Aged Examples
Figure Others Examples
Figure EMEA Anti-Obesity Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Anti-Obesity Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Anti-Obesity Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anti-Obesity Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Anti-Obesity Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Share by Players (2012-2017)
Figure 2016 Anti-Obesity Drugs Sales Share by Players
Figure 2017 Anti-Obesity Drugs Sales Share by Players
Figure EMEA Anti-Obesity Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Anti-Obesity Drugs Revenue Share by Players
Table 2017 EMEA Anti-Obesity Drugs Revenue Share by Players
Table EMEA Anti-Obesity Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Anti-Obesity Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Type (2012-2017)
Figure EMEA Anti-Obesity Drugs Sales Market Share by Type (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Obesity Drugs by Type in 2016
Table EMEA Anti-Obesity Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Anti-Obesity Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Application (2012-2017)
Figure EMEA Anti-Obesity Drugs Sales Market Share by Application in 2016
Table EMEA Anti-Obesity Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Region (2012-2017)
Figure EMEA Anti-Obesity Drugs Sales Market Share in 2016
Table EMEA Anti-Obesity Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Anti-Obesity Drugs by Region (2012-2017)
Figure EMEA Anti-Obesity Drugs Revenue Market Share Regions in 2016
Table EMEA Anti-Obesity Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
Table Europe Anti-Obesity Drugs Sales (K Units) by Type (2012-2017)
Table Europe Anti-Obesity Drugs Market Share by Type (2012-2017)
Figure Europe Anti-Obesity Drugs Market Share by Type in 2016
Table Europe Anti-Obesity Drugs Sales (K Units) by Application (2012-2017)
Table Europe Anti-Obesity Drugs Market Share by Application (2012-2017)
Figure Europe Anti-Obesity Drugs Market Share by Application in 2016
Table Europe Anti-Obesity Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Anti-Obesity Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Anti-Obesity Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Anti-Obesity Drugs Sales Market Share by Countries in 2016
Table Europe Anti-Obesity Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-Obesity Drugs Revenue Market Share by Countries in 2016
Figure Germany Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Anti-Obesity Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Anti-Obesity Drugs Market Share by Type (2012-2017)
Figure Middle East Anti-Obesity Drugs Market Share by Type (2012-2017)
Table Middle East Anti-Obesity Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Anti-Obesity Drugs Market Share by Applications (2012-2017)
Figure Middle East Anti-Obesity Drugs Sales Market Share by Application in 2016
Table Middle East Anti-Obesity Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Anti-Obesity Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Anti-Obesity Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Anti-Obesity Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-Obesity Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Anti-Obesity Drugs Sales (K Units) by Type (2012-2017)
Table Africa Anti-Obesity Drugs Sales Market Share by Type (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Type (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Type in 2016
Table Africa Anti-Obesity Drugs Sales (K Units) by Application (2012-2017)
Table Africa Anti-Obesity Drugs Sales Market Share by Application (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Application (2012-2017)
Table Africa Anti-Obesity Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Anti-Obesity Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Countries in 2016
Table Africa Anti-Obesity Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-Obesity Drugs Revenue Market Share by Countries in 2016
Figure South Africa Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Anti-Obesity Drugs Basic Information List
Table Pfizer Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck Anti-Obesity Drugs Basic Information List
Table Merck Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table F.Hoffmann-La Roche Anti-Obesity Drugs Basic Information List
Table F.Hoffmann-La Roche Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Anti-Obesity Drugs Basic Information List
Table GlaxoSmithKline Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Anti-Obesity Drugs Basic Information List
Table AstraZeneca Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Anti-Obesity Drugs Basic Information List
Table Boehringer Ingelheim Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Anti-Obesity Drugs Basic Information List
Table Novo Nordisk Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Eisai Anti-Obesity Drugs Basic Information List
Table Eisai Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eisai Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Eisai Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Eisai Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Norgine Anti-Obesity Drugs Basic Information List
Table Norgine Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Norgine Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Norgine Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Norgine Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Arena Pharmaceuticals Anti-Obesity Drugs Basic Information List
Table Arena Pharmaceuticals Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Orexigen Therapeutics Anti-Obesity Drugs Basic Information List
Table Vivus Anti-Obesity Drugs Basic Information List
Table Alizyme Anti-Obesity Drugs Basic Information List
Table Rhythm Pharmaceuticals Anti-Obesity Drugs Basic Information List
Table Shionogi Anti-Obesity Drugs Basic Information List
Table Zafgan Anti-Obesity Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drugs
Figure Manufacturing Process Analysis of Anti-Obesity Drugs
Figure Anti-Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2016
Table Major Buyers of Anti-Obesity Drugs
Table Distributors/Traders List
Figure EMEA Anti-Obesity Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-Obesity Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-Obesity Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Anti-Obesity Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Anti-Obesity Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Anti-Obesity Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Anti-Obesity Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Anti-Obesity Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Anti-Obesity Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Anti-Obesity Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Anti-Obesity Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-Obesity Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Anti-Obesity Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-Obesity Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Anti-Obesity Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Anti-Obesity Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Anti-Obesity Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Anti-Obesity Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Anti-Obesity Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Anti-Obesity Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Anti-Obesity Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Anti-Obesity Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Anti-Obesity Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top